Hepatitis and HIV

The purpose of the Hepatitis & HIV Scientific Working Group (H&H SWG) is to foster collaboration and innovation among researchers, clinicians, and educators across the Harvard University Center for AIDS Research (HU CFAR) to advance understanding and treatment of HIV and hepatitis infections. World wide projections indicate that Viral hepatitis deaths projected to exceed TB, HIV, malaria (see below image).

Thomas et al. NEJM 2019; Projections from Foreman et al. Lancet 2018;392:2052-2090
Thomas et al. NEJM 2019; Projections from Foreman et al. Lancet 2018;392:2052-2090

The aims of the Hepatitis & HIV Scientific Working Group are to focus on knowledge exchange and forging collaborations via:

  1. Quarterly meetings of the HU CFAR H&H SWG;
  2. Organizing, producing, and hosting an interdisciplinary symposium focused on hepatitis & HIV research; and
  3. Providing formal structured mentorship opportunities focused on hepatitis and HIV.

Directors: Arthur Kim, MD; Georg M. Lauer, MD